PLA2G2D and colitis: Using knockout mouse lines for various sPLA2s, we have recently shown that sPLA2-X preferentially mobilizes anti-inflammatory ω3 PUFAs including DHA and EPA, which block harmful Th17-type immune responses and thereby attenuate colitis partly through the fatty acid receptor GPR12024.